NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Zencore Biologics

Zencore Biologics

Private
Shanghai, ShanghaiHealthcare & Life Scienceswww.zgbiotech.com

Last Round

Series C

Extension

Aug 18, 2022

Total Funding Raised

$235.74M

Company Overview

Zencore Biologics is a biopharmaceutical company providing comprehensive contract development and manufacturing (CDMO) services that support pharmaceutical enterprises in the development and production of macromolecular drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMObiologics CDMOGMP manufacturingcontract development and manufacturing organizationbiologics manufacturingbiomanufacturingantibody manufacturingcontract manufacturingADC servicesCMC servicescell line developmentprocess developmentdrug substance manufacturingdrug product manufacturingchemistry, manufacturing, and controlsclinical trial manufacturingcell culture mediacommercial manufacturinganalytical servicesregulatory support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zencore Biologics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zencore Biologics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionAug 18, 2022
Series COct 27, 2021
Series BMar 22, 2021
Series AMar 30, 2020

Zencore Biologics Investors

Notable investors and investment history

InvestorRounds
IDG CapitalSeries C, Series A, Series B
招银国际金融有限公司Series B
Guoke Jiahe CapitalSeries B
LYFE CapitalSeries C, Series B, Series A
Sofina S.A.Series C
Goldman Sachs Growth EquitySeries C
Cowin CapitalSeries C

Zencore Biologics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zencore Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zencore Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2017
Last FundingAug 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.